F. Hoffmann-La Roche Ltd - Company Profile
Powered by 
All the sales intelligence you need on F. Hoffmann-La Roche Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how F. Hoffmann-La Roche Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with F. Hoffmann-La Roche Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
F. Hoffmann-La Roche Ltd (Roche), a subsidiary of Roche Holding AG, is one of the prominent research-based healthcare groups in the world. Focus on innovation enabled Roche to come up with a regular flow of new drugs and diagnostics, established market position, and strategic partnerships are its strengths, even as the vulnerability to substitute products could be a cause for concern. Regulatory approvals, growing market for cancer treatments, and strategic contracts and agreements could provide ample growth opportunities for the company. However, intense competition, uncertain R&D outcomes and government regulations could hamper Roche’s business, operating results and financial position.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer